http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 22 May 2024 12:57:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.%2C+Targets+Revolutionary+New+ABBIE+Genome+Editing+Kits+for+Q3%2C+2024/23263468.html <p align="left">CHINO HILLS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN)– a leading generic pharmaceutical and upstart biotechnology company, is proud to announce its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. This groundbreaking technology has the potential to revolutionize genome editing by allowing for precise and targeted integration of predesigned donor DNA into the genome of cells.</p> <p>The impact of ABBIE on genome editing cannot be overstated. By providing researchers with a powerful tool for targeted integration http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.%2C+Targets+Revolutionary+New+ABBIE+Genome+Editing+Kits+for+Q3%2C+2024/23263468.html Wed, 22 May 2024 12:57:00 -0400 O.29779944 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.%2C+Targets+Revolutionary+New+ABBIE+Genome+Editing+Kits+for+Q3%2C+2024/23263468.html <p align="left">CHINO HILLS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN)– a leading generic pharmaceutical and upstart biotechnology company, is proud to announce its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. This groundbreaking technology has the potential to revolutionize genome editing by allowing for precise and targeted integration of predesigned donor DNA into the genome of cells.</p> <p>The impact of ABBIE on genome editing cannot be overstated. By providing researchers with a powerful tool for targeted integration http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.%2C+Targets+Revolutionary+New+ABBIE+Genome+Editing+Kits+for+Q3%2C+2024/23263468.html Wed, 22 May 2024 12:57:00 -0400 O.29779944 SHMN http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.%2C+Targets+Revolutionary+New+ABBIE+Genome+Editing+Kits+for+Q3%2C+2024/23263468.html <p align="left">CHINO HILLS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN)– a leading generic pharmaceutical and upstart biotechnology company, is proud to announce its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. This groundbreaking technology has the potential to revolutionize genome editing by allowing for precise and targeted integration of predesigned donor DNA into the genome of cells.</p> <p>The impact of ABBIE on genome editing cannot be overstated. By providing researchers with a powerful tool for targeted integration http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.%2C+Targets+Revolutionary+New+ABBIE+Genome+Editing+Kits+for+Q3%2C+2024/23263468.html Wed, 22 May 2024 12:57:00 -0400 O.29779944 SHMN http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.%2C+Targets+Revolutionary+New+ABBIE+Genome+Editing+Kits+for+Q3%2C+2024/23263468.html <p align="left">CHINO HILLS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN)– a leading generic pharmaceutical and upstart biotechnology company, is proud to announce its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. This groundbreaking technology has the potential to revolutionize genome editing by allowing for precise and targeted integration of predesigned donor DNA into the genome of cells.</p> <p>The impact of ABBIE on genome editing cannot be overstated. By providing researchers with a powerful tool for targeted integration http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.%2C+Targets+Revolutionary+New+ABBIE+Genome+Editing+Kits+for+Q3%2C+2024/23263468.html Wed, 22 May 2024 12:57:00 -0400 O.29779944 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+and+Coastar+Therapeutics+Sign+MoU+and+Announce+Collaboration+to+Revolutionize+Genome+Editing+Using+Red+Blood+Cell+Membrane+Derived+Carriers/23004822.html <p>CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via<strong> </strong>IBN<strong> </strong>--<strong> </strong>SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems, and SOHM, a cutting-edge biopharmaceutical company focused on gene editing technologies, are excited to announce their collaboration to advance the field of genome editing using Coastar&apos;s red blood cell membrane derived carriers and SOHM&apos;s ABBIE (A Binding Based Integrase Enzyme) genome editing technology.</p> <p>Genome editing, particularly http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+and+Coastar+Therapeutics+Sign+MoU+and+Announce+Collaboration+to+Revolutionize+Genome+Editing+Using+Red+Blood+Cell+Membrane+Derived+Carriers/23004822.html Mon, 01 Apr 2024 09:30:00 -0400 O.29779944 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+and+Coastar+Therapeutics+Sign+MoU+and+Announce+Collaboration+to+Revolutionize+Genome+Editing+Using+Red+Blood+Cell+Membrane+Derived+Carriers/23004822.html <p>CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via<strong> </strong>IBN<strong> </strong>--<strong> </strong>SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems, and SOHM, a cutting-edge biopharmaceutical company focused on gene editing technologies, are excited to announce their collaboration to advance the field of genome editing using Coastar&apos;s red blood cell membrane derived carriers and SOHM&apos;s ABBIE (A Binding Based Integrase Enzyme) genome editing technology.</p> <p>Genome editing, particularly http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+and+Coastar+Therapeutics+Sign+MoU+and+Announce+Collaboration+to+Revolutionize+Genome+Editing+Using+Red+Blood+Cell+Membrane+Derived+Carriers/23004822.html Mon, 01 Apr 2024 09:30:00 -0400 O.29779944 SHMN http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+and+Coastar+Therapeutics+Sign+MoU+and+Announce+Collaboration+to+Revolutionize+Genome+Editing+Using+Red+Blood+Cell+Membrane+Derived+Carriers/23004822.html <p>CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via<strong> </strong>IBN<strong> </strong>--<strong> </strong>SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems, and SOHM, a cutting-edge biopharmaceutical company focused on gene editing technologies, are excited to announce their collaboration to advance the field of genome editing using Coastar&apos;s red blood cell membrane derived carriers and SOHM&apos;s ABBIE (A Binding Based Integrase Enzyme) genome editing technology.</p> <p>Genome editing, particularly http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+and+Coastar+Therapeutics+Sign+MoU+and+Announce+Collaboration+to+Revolutionize+Genome+Editing+Using+Red+Blood+Cell+Membrane+Derived+Carriers/23004822.html Mon, 01 Apr 2024 09:30:00 -0400 O.29779944 SHMN http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+and+Coastar+Therapeutics+Sign+MoU+and+Announce+Collaboration+to+Revolutionize+Genome+Editing+Using+Red+Blood+Cell+Membrane+Derived+Carriers/23004822.html <p>CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via<strong> </strong>IBN<strong> </strong>--<strong> </strong>SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems, and SOHM, a cutting-edge biopharmaceutical company focused on gene editing technologies, are excited to announce their collaboration to advance the field of genome editing using Coastar&apos;s red blood cell membrane derived carriers and SOHM&apos;s ABBIE (A Binding Based Integrase Enzyme) genome editing technology.</p> <p>Genome editing, particularly http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+and+Coastar+Therapeutics+Sign+MoU+and+Announce+Collaboration+to+Revolutionize+Genome+Editing+Using+Red+Blood+Cell+Membrane+Derived+Carriers/23004822.html Mon, 01 Apr 2024 09:30:00 -0400 O.29779944 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html <p>CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- <strong>via IBN -- SOHM, Inc.</strong> (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the appointment of <strong>Dr. Krishna Bhat, MD. Ph.D., FACC.</strong>, an experienced bioscientist and cardiologist, to serve on the company’s Advisory Board as a Chief Medical Advisor.</p> <p>Baron Night, SOHM president and CEO, said <strong>Dr. Bhat </strong>has a cardiology practice of over 35 years in the field of Clinical and Interventional Cardiology. He is a recipient of the 2021 Hall of Fame Award from http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html Thu, 24 Aug 2023 06:30:00 -0400 A.07275906 O.29779944 O.31842592 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html <p>CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- <strong>via IBN -- SOHM, Inc.</strong> (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the appointment of <strong>Dr. Krishna Bhat, MD. Ph.D., FACC.</strong>, an experienced bioscientist and cardiologist, to serve on the company’s Advisory Board as a Chief Medical Advisor.</p> <p>Baron Night, SOHM president and CEO, said <strong>Dr. Bhat </strong>has a cardiology practice of over 35 years in the field of Clinical and Interventional Cardiology. He is a recipient of the 2021 Hall of Fame Award from http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html Thu, 24 Aug 2023 06:30:00 -0400 A.07275906 O.29779944 O.31842592 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html <p>CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- <strong>via IBN -- SOHM, Inc.</strong> (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the appointment of <strong>Dr. Krishna Bhat, MD. Ph.D., FACC.</strong>, an experienced bioscientist and cardiologist, to serve on the company’s Advisory Board as a Chief Medical Advisor.</p> <p>Baron Night, SOHM president and CEO, said <strong>Dr. Bhat </strong>has a cardiology practice of over 35 years in the field of Clinical and Interventional Cardiology. He is a recipient of the 2021 Hall of Fame Award from http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html Thu, 24 Aug 2023 06:30:00 -0400 A.07275906 O.29779944 O.31842592 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html <p>CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- <strong>via IBN -- SOHM, Inc.</strong> (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the appointment of <strong>Dr. Krishna Bhat, MD. Ph.D., FACC.</strong>, an experienced bioscientist and cardiologist, to serve on the company’s Advisory Board as a Chief Medical Advisor.</p> <p>Baron Night, SOHM president and CEO, said <strong>Dr. Bhat </strong>has a cardiology practice of over 35 years in the field of Clinical and Interventional Cardiology. He is a recipient of the 2021 Hall of Fame Award from http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html Thu, 24 Aug 2023 06:30:00 -0400 A.07275906 O.29779944 O.31842592 SHMN http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html <p>CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- <strong>via IBN -- SOHM, Inc.</strong> (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the appointment of <strong>Dr. Krishna Bhat, MD. Ph.D., FACC.</strong>, an experienced bioscientist and cardiologist, to serve on the company’s Advisory Board as a Chief Medical Advisor.</p> <p>Baron Night, SOHM president and CEO, said <strong>Dr. Bhat </strong>has a cardiology practice of over 35 years in the field of Clinical and Interventional Cardiology. He is a recipient of the 2021 Hall of Fame Award from http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html Thu, 24 Aug 2023 06:30:00 -0400 A.07275906 O.29779944 O.31842592 SHMN http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html <p>CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- <strong>via IBN -- SOHM, Inc.</strong> (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the appointment of <strong>Dr. Krishna Bhat, MD. Ph.D., FACC.</strong>, an experienced bioscientist and cardiologist, to serve on the company’s Advisory Board as a Chief Medical Advisor.</p> <p>Baron Night, SOHM president and CEO, said <strong>Dr. Bhat </strong>has a cardiology practice of over 35 years in the field of Clinical and Interventional Cardiology. He is a recipient of the 2021 Hall of Fame Award from http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html Thu, 24 Aug 2023 06:30:00 -0400 A.07275906 O.29779944 O.31842592 SHMN http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html <p>CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- <strong>via IBN -- SOHM, Inc.</strong> (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the appointment of <strong>Dr. Krishna Bhat, MD. Ph.D., FACC.</strong>, an experienced bioscientist and cardiologist, to serve on the company’s Advisory Board as a Chief Medical Advisor.</p> <p>Baron Night, SOHM president and CEO, said <strong>Dr. Bhat </strong>has a cardiology practice of over 35 years in the field of Clinical and Interventional Cardiology. He is a recipient of the 2021 Hall of Fame Award from http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html Thu, 24 Aug 2023 06:30:00 -0400 A.07275906 O.29779944 O.31842592 SHMN http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html <p>CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- <strong>via IBN -- SOHM, Inc.</strong> (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the appointment of <strong>Dr. Krishna Bhat, MD. Ph.D., FACC.</strong>, an experienced bioscientist and cardiologist, to serve on the company’s Advisory Board as a Chief Medical Advisor.</p> <p>Baron Night, SOHM president and CEO, said <strong>Dr. Bhat </strong>has a cardiology practice of over 35 years in the field of Clinical and Interventional Cardiology. He is a recipient of the 2021 Hall of Fame Award from http://www.streetinsider.com/Globe+Newswire/SOHM%2C+Inc.+Expands+Its+Advisory+Board%2C+Appointing+Dr.+Krishna+Bhat%2C+M.D%2C+Ph.D.%2C+FACC%2C+as+Chief+Medical+Advisor/22082842.html Thu, 24 Aug 2023 06:30:00 -0400 A.07275906 O.29779944 O.31842592 SHMN http://www.streetinsider.com/Press+Releases/NOTICE+TO+DISREGARD+-+SOHM%2C+Inc./14494943.html si-local-file:///var/storage/newsbody/2018/0809/14494943.html http://www.streetinsider.com/Press+Releases/NOTICE+TO+DISREGARD+-+SOHM%2C+Inc./14494943.html Thu, 09 Aug 2018 12:14:00 -0400 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Subsidiary+Daiichi+Sankyo+Group+Files+Its+Acute+Myeloid+Leukemia+%28AML%29+Treatment+Quizartinib+in+the+US%3B+the+FDA+Awarded+Breakthrough+Status+for+The+Drug/14494463.html si-local-file:///var/storage/newsbody/2018/0809/14494463.html http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Subsidiary+Daiichi+Sankyo+Group+Files+Its+Acute+Myeloid+Leukemia+%28AML%29+Treatment+Quizartinib+in+the+US%3B+the+FDA+Awarded+Breakthrough+Status+for+The+Drug/14494463.html Thu, 09 Aug 2018 10:34:00 -0400 SHMN http://www.streetinsider.com/Press+Releases/DELETED%3A+SOHM%2C+Inc.+Subsidiary+Daiichi+Sankyo+Group+Files+Its+Acute+Myeloid+Leukemia+%28AML%29+Treatment+Quizartinib+in+the+US%3B+the+FDA+Awarded+Breakthrough+Status+for+The+Drug/14495371.html <p>This story has been deleted by the news provider.</p> http://www.streetinsider.com/Press+Releases/DELETED%3A+SOHM%2C+Inc.+Subsidiary+Daiichi+Sankyo+Group+Files+Its+Acute+Myeloid+Leukemia+%28AML%29+Treatment+Quizartinib+in+the+US%3B+the+FDA+Awarded+Breakthrough+Status+for+The+Drug/14495371.html Thu, 09 Aug 2018 10:34:00 -0400 SHMN SHMN http://www.streetinsider.com/Press+Releases/DELETED%3A+SOHM%2C+Inc.+Subsidiary+Daiichi+Sankyo+Group+Files+Its+Acute+Myeloid+Leukemia+%28AML%29+Treatment+Quizartinib+in+the+US%3B+the+FDA+Awarded+Breakthrough+Status+for+The+Drug/14495371.html <p>This story has been deleted by the news provider.</p> http://www.streetinsider.com/Press+Releases/DELETED%3A+SOHM%2C+Inc.+Subsidiary+Daiichi+Sankyo+Group+Files+Its+Acute+Myeloid+Leukemia+%28AML%29+Treatment+Quizartinib+in+the+US%3B+the+FDA+Awarded+Breakthrough+Status+for+The+Drug/14495371.html Thu, 09 Aug 2018 10:34:00 -0400 SHMN SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Announces+Potential+Purchase+Orders+for+a+Range+of+Pharmaceutical+Products/14465748.html si-local-file:///var/storage/newsbody/2018/0802/14465748.html http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Announces+Potential+Purchase+Orders+for+a+Range+of+Pharmaceutical+Products/14465748.html Thu, 02 Aug 2018 10:18:00 -0400 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Fully+Paid+Nevada+Secretary+of+State+Fee+and+is+Seeking+to+be+OTC+Current%C2%A0/14459759.html si-local-file:///var/storage/newsbody/2018/0801/14459759.html http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Fully+Paid+Nevada+Secretary+of+State+Fee+and+is+Seeking+to+be+OTC+Current%C2%A0/14459759.html Wed, 01 Aug 2018 12:44:00 -0400 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Files+All+Quarterly+and+Annual+Financials+to+Move+Current+with+OTC/14437057.html si-local-file:///var/storage/newsbody/2018/0726/14437057.html http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Files+All+Quarterly+and+Annual+Financials+to+Move+Current+with+OTC/14437057.html Thu, 26 Jul 2018 10:47:00 -0400 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Announces+No+Reverse+Split+and+No+Increase+of+Authorize+Shares/14427437.html si-local-file:///var/storage/newsbody/2018/0724/14427437.html http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Announces+No+Reverse+Split+and+No+Increase+of+Authorize+Shares/14427437.html Tue, 24 Jul 2018 12:54:00 -0400 SHMN http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Reports+%24180%2C000+of+Total+Revenue+and+a+Gross+Profit+of+%2495%2C292+for+the+First+Qtr+of+2018/14406080.html si-local-file:///var/storage/newsbody/2018/0717/14406080.html http://www.streetinsider.com/Press+Releases/SOHM%2C+Inc.+Reports+%24180%2C000+of+Total+Revenue+and+a+Gross+Profit+of+%2495%2C292+for+the+First+Qtr+of+2018/14406080.html Tue, 17 Jul 2018 10:11:00 -0400 SHMN